Bellicum Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Bellicum Pharmaceuticals patents 12 in total

Status Patent
Application
Utility: IMPROVED FORMULATIONS FOR IMMUNE CELLS External link
Filling date: 8 Sep 2025 Issue date: 1 Sep 2022
Application
Utility: METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS External link
Filling date: 8 Sep 2025 Issue date: 19 May 2022
Application
Utility: METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS External link
Filling date: 8 Sep 2025 Issue date: 28 Apr 2022
Application
Utility: PSCA CAR-T CELLS External link
Filling date: 8 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: T CELLS WITH SUICIDE SWITCH External link
Filling date: 8 Sep 2025 Issue date: 6 Jan 2022
Application
Utility: COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES External link
Filling date: 8 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: METHODS TO AUGMENT OR ALTER SIGNAL TRANSDUCTION External link
Filling date: 8 Sep 2025 Issue date: 20 May 2021
Application
Utility: NATURAL KILLER CELL PRODUCTS AND METHODS External link
Filling date: 8 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: METHODS FOR ENHANCING AND MAINTAINING CAR-T CELL EFFICACY External link
Filling date: 8 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: Multimeric piperidine derivatives External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES External link
Filling date: 8 Sep 2025 Issue date: 23 Jul 2020

Showing 1 to 12 of 12 patents.